BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 22703863)

  • 1. Retrospective review of pelvic malignancies undergoing total pelvic exenteration.
    Kuhrt MP; Chokshi RJ; Arrese D; Martin EW
    World J Surg Oncol; 2012 Jun; 10():110. PubMed ID: 22703863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of pelvic exenteration for locally advanced primary or recurrent non-colorectal pelvic malignancies.
    Ueda T; Koyama F; Nakagawa T; Nakamura S; Nishigori N; Inoue T; Kawasaki K; Obara S; Nakamoto T; Fujii H; Nakajima Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2433-6. PubMed ID: 24394136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-institution approach to total pelvic exenteration.
    Chokshi RJ; Fowler J; Cohn D; Bahnson R; Lumbley J; Martin EW
    Am Surg; 2011 Dec; 77(12):1629-39. PubMed ID: 22273221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
    [No Abstract]   [Full Text] [Related]  

  • 6. Pelvic local recurrence from colorectal cancer: surgical challenge with changing preconditions.
    Iversen H; Martling A; Johansson H; Nilsson PJ; Holm T
    Colorectal Dis; 2018 May; 20(5):399-406. PubMed ID: 29161761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
    PelvExCollaborative
    Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genitourinary tract preservation versus pelvic exenteration for advanced colorectal tumors.
    Muruve N
    Can J Urol; 2003 Apr; 10(2):1815-8. PubMed ID: 12773233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Layer-oriented total pelvic exenteration for locally advanced primary colorectal cancer.
    Koda K; Shuto K; Matsuo K; Kosugi C; Mori M; Hirano A; Hiroshima Y; Tanaka K
    Int J Colorectal Dis; 2016 Jan; 31(1):59-66. PubMed ID: 26255259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total pelvic exenteration for the treatment of advanced primary or recurrent pelvic neoplasia.
    Carballo L; Enríquez-Navascués JM; Saralegui Y; Placer C; Timoteo A; Borda N; Carrillo A; Sainz-Lete A
    Cir Esp; 2015 Mar; 93(3):174-80. PubMed ID: 25443154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer.
    Jimenez RE; Shoup M; Cohen AM; Paty PB; Guillem J; Wong WD
    Dis Colon Rectum; 2003 Dec; 46(12):1619-25. PubMed ID: 14668586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pushing the boundaries of pelvic exenteration by maintaining survival at the cost of morbidity.
    Venchiarutti RL; Solomon MJ; Koh CE; Young JM; Steffens D
    Br J Surg; 2019 Sep; 106(10):1393-1403. PubMed ID: 31282571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
    Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic exenteration for advanced and recurrent malignancy.
    Zoucas E; Frederiksen S; Lydrup ML; Månsson W; Gustafson P; Alberius P
    World J Surg; 2010 Sep; 34(9):2177-84. PubMed ID: 20512493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer.
    Rottoli M; Vallicelli C; Boschi L; Poggioli G
    Int J Surg; 2017 Dec; 48():69-73. PubMed ID: 28987560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curative pelvic exenteration: initial experience and clinical outcome.
    Ali Uraiqat A; Al Nsour D; Mestareehy KM; Allababdeh MS; Naffa MTF; Alrabee MM; Al-Hammouri F
    Pan Afr Med J; 2023; 44():170. PubMed ID: 37455871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic exenteration for colorectal and non-colorectal cancer: a comparison of perioperative and oncological outcome.
    Bogner A; Fritzmann J; Müssle B; Huber J; Dobroschke J; Bork U; Wolk S; Distler M; Weitz J; Welsch T; Kahlert C
    Int J Colorectal Dis; 2021 Aug; 36(8):1701-1710. PubMed ID: 33677655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of advanced pelvic cancer by exenteration.
    Kecmanovic DM; Pavlov MJ; Kovacevic PA; Sepetkovski AV; Ceranic MS; Stamenkovic AB
    Eur J Surg Oncol; 2003 Nov; 29(9):743-6. PubMed ID: 14602493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total pelvic exenteration with or without sacral resection in patients with recurrent colorectal cancer.
    Sardi A; Bolton JS; Hicks TC; Skenderis BS
    South Med J; 1994 Mar; 87(3):363-9. PubMed ID: 7510906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic exenteration and sphincter preservation: an analysis of 96 cases.
    Poletto AH; Lopes A; Carvalho AL; Ribeiro EA; Vieira RA; Rossi BM; Aguiar S; Guimarães GC; Ferreira Fde O; Nakagawa WT
    J Surg Oncol; 2004 Jun; 86(3):122-7. PubMed ID: 15170649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.